The Impact of Climate Environment in Different Latitudes on the Occurrence of PICC Complications

Trial Title: The Impact of Climate Environment in Different Latitudes on the Occurrence of PICC Complications

NCT ID: NCT05870449

Condition: Cancer
Thrombus
Phlebitis
Infections

Conditions: Official terms:
Phlebitis

Study type: Interventional

Study phase: N/A

Overall status: Not yet recruiting

Study design:

Allocation: Randomized

Intervention model: Parallel Assignment

Primary purpose: Treatment

Masking: Single (Outcomes Assessor)

Intervention:

Intervention type: Device
Intervention name: tunneled PICC
Description: Tunneled PICC is a type of PICC catheterization technique that involves establishing a subcutaneous tunnel to keep the outlet of the catheter away from the puncture site
Arm group label: trial group

Intervention type: Device
Intervention name: routine PICC
Description: Peripherally inserted central venous catheterization is a technique that involves inserting PICC through the peripheral vein and infusing drugs into the central vein through a catheter.
Arm group label: control group

Summary: In this study, eligible subjects were randomly assigned to the experimental or control group through randomization (1:1). Under the guidance of electrocardiographic Doppler ultrasound guided puncture and catheterization (EDUG) technology, the tunnel puncture method was compared with the conventional puncture method. The two groups of patients were observed and evaluated intraoperative and postoperative 7 ± 3 days, 30 ± 7 days, 60 ± 10 days, and 90 ± 10 days 120 ± 10 days (if any) and the occurrence of complications during extubation or unplanned extubation at the end of treatment, comparing cases in the north and south, as well as complications related to different catheterization methods

Criteria for eligibility:
Criteria:
Inclusion Criteria: - Patients aged ≥ 18 years old; - Patients who follow medical advice and require PICC catheterization; - Patients who have not participated in other clinical studies; - Patients who voluntarily participate in this clinical study and can cooperate with clinical follow-up; - There are no serious cardiovascular diseases, such as atrial fibrillation, pulmonary heart disease, and other P-wave abnormalities before catheterization, as well as severe heart conduction block Exclusion Criteria: - Known allergies to catheter materials; - There is a history of infection, injury, and radiation therapy at the puncture site; - The puncture site has a history of venous thrombosis or surgery; - Severe abnormal coagulation function; - Superior vena cava compression syndrome; - Surgical side limbs of breast cancer patients undergoing radical mastectomy or axillary lymph node dissection; - Heart pacemaker and arteriovenous fistula on the same side of the limb; - Patients or patients' family members refuse to sign the informed consent form.

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Start date: July 1, 2023

Completion date: December 31, 2024

Lead sponsor:
Agency: Shandong Branden Med.Device Co.,Ltd
Agency class: Industry

Collaborator:
Agency: Hainan Cancer Hospital
Agency class: Other

Source: Shandong Branden Med.Device Co.,Ltd

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05870449